cGMP Adjuvant Commercial Scale Bulk Lot(s) And Fill-Finish of Adjuvant in Multi-Dose Vials
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- W15QKN-20-C-0048
- Agency
-
ACC Picatinny
Army Contracting Command, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W15QKN-20-C-0048 Federal contract award
- Awardee
- Glaxosmithkline, LLC
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Durham NC 27709 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Army Materiel Command Contracting Command at Picatinny Arsenal published a Limited/Sole Source Justification Notice for the manufacturing of cGMP adjuvant in commercial scale bulk lots and fill-finish of the adjuvant in multi-dose vials to support adjuvant production. A redacted justification and approval document provides the rationale for awarding contract number W15QKN-20-C-0048 on July 30, 2020 to an unknown vendor for an unknown amount to produce cGMP adjuvant in bulk and fill it into multi-dose vials.
Notice text
Redacted J&A Included
Awarded contract W15QKN-20-C-0048 to unknown vendor for unknown amount on 2020-07-30.
Files
| File | Type | Posted |
|---|---|---|
| GSK AS03 Redacted JA.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| cGMP Adjuvant Commercial Scale Bulk Lot(s) And Fill-Finish of Adjuvant in Multi-Dose Vials | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity